Search Within

Hyejin Choi

Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Department of Medicine (8)
  2. Melanoma and Immunotherapeutics Service (8)
  3. Sloan Kettering Institute Postdocs (8)
  4. Solid Tumor Oncology Division (8)
  5. GSK Faculty (7)
  6. MSK Grad Students (5)

More Groups

People
  1. Taha Merghoub (8)
  2. Jedd Wolchok (6)
  3. Lauren Dong (5)
  4. Neal Rosen (3)
  5. Nezar Mehanna (3)
  6. Sadna Budhu (3)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (1)
  6. 2018 (1)
Publications
  1. Cancer Research (2)
  2. Cell Reports (1)
  3. Clinical Cancer Research (1)
  4. Journal for ImmunoTherapy of Cancer (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (1)
  3. Biomed Central Ltd (1)
  4. Cell Press (1)
  5. Rockefeller University Press (1)
  6. The American Association of Immunologists, Inc (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
    Journal Article

    Robles-Oteíza, C.; Hastings, K.; Choi, J.; Sirois, I.; Ravi, A.; Expósito, F.; de Miguel, F.; Knight, J. R.; López-Giráldez, F.; Choi, H.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pulsatile MEK inhibition improves anti-tumor immunity and T cell function in Kras mutant lung cancer
    Meeting Abstract

    Choi, H.; Deng, J.; Li, S.; Silk, T.; Dong, L.; Brea, E. J.; Houghton, S.; Redmond, D.; Zhong, H.; Boiarsky, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Mehanna, N.; Falik, N.; Rosen, N.; Merghoub, T.; Wolchok, J. D.
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
    Journal Article

    Hellmann, M. D.; Nabet, B. Y.; Rizvi, H.; Chaudhuri, A. A.; Wells, D. K.; Dunphy, M. P. S.; Chabon, J. J.; Liu, C. L.; Hui, A. B.; Arbour, K. C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Pulsatile MEK inhibition improves anti-tumor immunity and T cell function in murine Kras mutant lung cancer
    Journal Article

    Choi, H.; Deng, J.; Li, S.; Silk, T.; Dong, L.; Brea, E. J.; Houghton, S.; Redmond, D.; Zhong, H.; Boiarsky, J.; more...
    Cell Reports (2019)

    Fulltext@MSK | Save
  • Exploring effects of MEK inhibition in tumor microenvironment in non-small cell lung cancer (NSCLC) pre-clinical models
    Meeting Abstract

    Silk, T.; Choi, H.; Deng, J.; Pourpe, S.; Wong, K. K.; Merghoub, T.; Wolchok, J. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save